Market Cap 479.84M
Revenue (ttm) 850,000.00
Net Income (ttm) -49.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5,809.41%
Debt to Equity Ratio 0.00
Volume 1,584,500
Avg Vol 1,367,386
Day's Range N/A - N/A
Shares Out 138.28M
Stochastic %K 75%
Beta 1.48
Analysts Strong Sell
Price Target $13.20

Company Profile

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidates include tovecimig, a bispecific antibody that blocks Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A) signaling pathways, which are critical to angiogenesis and tumor vascularization; CTX-471, an IgG4 monoclonal antibody...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 500 8099
Address:
80 Guest Street, Suite 601, Boston, United States
lexlut
lexlut Oct. 3 at 7:34 PM
0 · Reply
lexlut
lexlut Oct. 3 at 1:51 PM
1 · Reply
King_of_Bio
King_of_Bio Oct. 3 at 1:44 PM
$TSHA $GOSS $CMPX $TNYA If you don't have at least ONE of these bio-stocks in your portfolio, what ARE you doing? Savvy investors investors know, it's always bio season :)
1 · Reply
highnihilism
highnihilism Oct. 1 at 9:18 AM
$TWO Two Harbors Investment Trade Count: 113 | Total $: 10 K | 0.19 × 90-Day Avg $: 52.9 K | Call $: 3.7 K | Put $: 6.2 K | % Single-Leg: 94% | % Multi-Leg: 6% | % Contingent: – $AHR American Healthcare REIT Trade Count: 8 | Total $: 3.7 K | 0.59 × 90-Day Avg $: 6.3 K | Call $: 3.7 K | Put $: 0 | % Single-Leg: 0% | % Multi-Leg: 0% | % Contingent: 100% $PLSE Pulse Biosciences Trade Count: 5 | Total $: 4.1 K | 0.47 × 90-Day Avg $: 8.8 K | Call $: 3.7 K | Put $: 370 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $CMPX Compass Therapeutics Trade Count: 14 | Total $: 3.7 K | 0.59 × 90-Day Avg $: 6.3 K | Call $: 3.7 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
lexlut
lexlut Sep. 30 at 3:46 PM
$CMPX $MBRX Moneyyyyy
0 · Reply
lexlut
lexlut Sep. 30 at 6:41 AM
$CMPX 4$ today
0 · Reply
lexlut
lexlut Sep. 26 at 4:19 PM
0 · Reply
lexlut
lexlut Sep. 26 at 8:32 AM
$OCGN $MBRX $CMPX Bullish today
0 · Reply
lexlut
lexlut Sep. 23 at 8:12 PM
@WarrenBuffettCEO $CMPX
0 · Reply
lexlut
lexlut Sep. 23 at 2:47 PM
0 · Reply
Latest News on CMPX
Compass Therapeutics Announces Proposed Public Offering

Aug 12, 2025, 4:01 PM EDT - 7 weeks ago

Compass Therapeutics Announces Proposed Public Offering


Compass Therapeutics to Participate in Upcoming Investor Events

Nov 13, 2024, 8:30 AM EST - 11 months ago

Compass Therapeutics to Participate in Upcoming Investor Events


Compass Therapeutics: Pointing Right At Some Tough Cancers

Jun 20, 2024, 3:14 AM EDT - 1 year ago

Compass Therapeutics: Pointing Right At Some Tough Cancers


Compass Therapeutics Announces CEO Transition

May 28, 2024, 4:10 PM EDT - 1 year ago

Compass Therapeutics Announces CEO Transition


Compass Therapeutics Provides Corporate Update

Jan 5, 2024, 8:00 AM EST - 1 year ago

Compass Therapeutics Provides Corporate Update


lexlut
lexlut Oct. 3 at 7:34 PM
0 · Reply
lexlut
lexlut Oct. 3 at 1:51 PM
1 · Reply
King_of_Bio
King_of_Bio Oct. 3 at 1:44 PM
$TSHA $GOSS $CMPX $TNYA If you don't have at least ONE of these bio-stocks in your portfolio, what ARE you doing? Savvy investors investors know, it's always bio season :)
1 · Reply
highnihilism
highnihilism Oct. 1 at 9:18 AM
$TWO Two Harbors Investment Trade Count: 113 | Total $: 10 K | 0.19 × 90-Day Avg $: 52.9 K | Call $: 3.7 K | Put $: 6.2 K | % Single-Leg: 94% | % Multi-Leg: 6% | % Contingent: – $AHR American Healthcare REIT Trade Count: 8 | Total $: 3.7 K | 0.59 × 90-Day Avg $: 6.3 K | Call $: 3.7 K | Put $: 0 | % Single-Leg: 0% | % Multi-Leg: 0% | % Contingent: 100% $PLSE Pulse Biosciences Trade Count: 5 | Total $: 4.1 K | 0.47 × 90-Day Avg $: 8.8 K | Call $: 3.7 K | Put $: 370 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $CMPX Compass Therapeutics Trade Count: 14 | Total $: 3.7 K | 0.59 × 90-Day Avg $: 6.3 K | Call $: 3.7 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
lexlut
lexlut Sep. 30 at 3:46 PM
$CMPX $MBRX Moneyyyyy
0 · Reply
lexlut
lexlut Sep. 30 at 6:41 AM
$CMPX 4$ today
0 · Reply
lexlut
lexlut Sep. 26 at 4:19 PM
0 · Reply
lexlut
lexlut Sep. 26 at 8:32 AM
$OCGN $MBRX $CMPX Bullish today
0 · Reply
lexlut
lexlut Sep. 23 at 8:12 PM
@WarrenBuffettCEO $CMPX
0 · Reply
lexlut
lexlut Sep. 23 at 2:47 PM
0 · Reply
lexlut
lexlut Sep. 22 at 11:21 AM
0 · Reply
lexlut
lexlut Sep. 19 at 4:05 PM
0 · Reply
ChavezAAron
ChavezAAron Sep. 19 at 6:24 AM
$CMPX its friday. Smart people will collect profits and start again on Monday. Im bullish for the long term, but for now, keep making money with it.
0 · Reply
Greenpa
Greenpa Sep. 17 at 7:45 PM
$CMPX Traders moving on from perceived momentum play? Good long term value but reason that raised at $3 as lots of near term hurdles and data needed. Still like potential out in 27/28 timeframe.
0 · Reply
highnihilism
highnihilism Sep. 17 at 11:59 AM
IWM: Russell 2000 → $CBZ Cbiz $CMPX Compass Therapeutics $MLNK Meridianlink $SAFT Safety Insurance Group $FSTR L.B. Foster Company
0 · Reply
Dr_Monkeybreath
Dr_Monkeybreath Sep. 16 at 12:39 PM
remember with $CMPX dipped under $1? me too! 👀for similar recovery soon at $GTBP 📈💵👍
0 · Reply
lexlut
lexlut Sep. 15 at 1:31 PM
0 · Reply
Tradetime3472
Tradetime3472 Sep. 12 at 1:43 AM
$CMPX CEO talks about the industry in this article. IMO I believe PBM is the most undervalued nasdaq listed psychedelic company. Also the only nature derived psilocybin & ibogaine Nasdaq company. https://www.statnews.com/2025/09/11/pharma-companies-investing-psychedelic-treatments/
1 · Reply
lexlut
lexlut Sep. 11 at 6:29 PM
0 · Reply
outlawinvestor1
outlawinvestor1 Sep. 11 at 9:03 AM
$SMMT at $14B, this stock remains overvalued. $BNTX, $CMPX, $CBIO and/or even $MRK are the better investments in this space imho.
1 · Reply
King_of_Bio
King_of_Bio Sep. 10 at 7:44 PM
$CMPX Looking good so far this month.
0 · Reply
lexlut
lexlut Sep. 10 at 1:51 PM
0 · Reply